跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
X-18
首页
药物
X-18
X-18
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
LABELING COMPOUND FOR PET
申请人: RIKEN
优先权: 2010
EP
Solid-Phase Preparation of [18F]Fluorohaloalkanes
申请人: BRADY FRANK
优先权: 2007
US
Compounds that Block the C5a Receptor and Their Use in Therapy
申请人: VAN STRIJP JOHANNES ANTONIUS GERARDUS
优先权: 2004
US
Methods and Agents for Preparing 18F-Radiolabeled Fluorinating Agents
申请人: DIMAGNO STEPHEN G
优先权: 2007
US
ALKYNE COMPOUND, VITAMIN D COMPOUND, ANALYTICAL METHOD, AND PRODUCTION METHOD
申请人: TOKYO UNIV OF AGRICULTURE AND TECHNOLOGY
优先权: 2021
EP
Radiolabeled subglutamic acid compound and application thereof in preparation of PET developer
申请人: TANG GANGHUA
优先权: 2019
CN
GLP-1/GCG/GIP TRIPLE-RECEPTOR AGONIST AND USE THEREOF
申请人: SUNSHINE LAKE PHARMA CO LTD
优先权: 2022
CN
EP
WO
4 件公开
GLP-1/GIP DUAL-TARGETED POLYPEPTIDE AND FUSION PROTEIN AND APPLICATIONS THEREOF
申请人: SUNSHINE LAKE PHARMA CO LTD
优先权: 2021
EP
药物
反馈